{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:57Z","timestamp":1787013957391,"version":"build-2736575974"},"reference-count":28,"publisher":"Wiley","issue":"16","license":[{"start":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T00:00:00Z","timestamp":1435276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Janssen Pharmaceutical Research and Development"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Purpose<\/jats:title>\n                    <jats:p>\n                      Small\u2010molecule inhibitors of prolyl hydroxylase (\n                      <jats:styled-content style=\"fixed-case\">PHD<\/jats:styled-content>\n                      ) enzymes are a novel target for the treatment of anaemia and functional iron deficiency (\n                      <jats:styled-content style=\"fixed-case\">FID<\/jats:styled-content>\n                      ). Other than being orally bioavailable, the differentiation of\n                      <jats:styled-content style=\"fixed-case\">PHD<\/jats:styled-content>\n                      inhibitors from recombinant human erythropoietin (\n                      <jats:styled-content style=\"fixed-case\">rhEPO<\/jats:styled-content>\n                      ) has not been demonstrated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Approach<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">JNJ<\/jats:styled-content>\n                      \u201042905343 was identified and characterized as a novel inhibitor of\n                      <jats:styled-content style=\"fixed-case\">PHD<\/jats:styled-content>\n                      and its action was compared with\n                      <jats:styled-content style=\"fixed-case\">rhEPO<\/jats:styled-content>\n                      in healthy rats and in a rat model of inflammation\u2010induced anaemia and\n                      <jats:styled-content style=\"fixed-case\">FID<\/jats:styled-content>\n                      [peptidoglycan\u2010polysaccharide (\n                      <jats:styled-content style=\"fixed-case\">PGPS<\/jats:styled-content>\n                      ) model].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      Oral administration of\n                      <jats:styled-content style=\"fixed-case\">JNJ<\/jats:styled-content>\n                      \u201042905343 to healthy rats increased the gene expression of cytochrome b (\n                      <jats:styled-content style=\"fixed-case\">DcytB<\/jats:styled-content>\n                      ) and divalent metal\u2010ion transporter 1 (\n                      <jats:styled-content style=\"fixed-case\">DMT1<\/jats:styled-content>\n                      ) in the duodenum, and increased plasma\n                      <jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>\n                      . Repeated administration of\n                      <jats:styled-content style=\"fixed-case\">JNJ<\/jats:styled-content>\n                      \u201042905343 for 28 days increased blood haemoglobin, mean corpuscular haemoglobin (\n                      <jats:styled-content style=\"fixed-case\">MCH<\/jats:styled-content>\n                      ) and mean corpuscular volume (\n                      <jats:styled-content style=\"fixed-case\">MCV<\/jats:styled-content>\n                      ). The serum iron concentration was increased with low doses (0.3\u2009mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) but reduced at high doses (6\u2009mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ). In\n                      <jats:styled-content style=\"fixed-case\">PGPS<\/jats:styled-content>\n                      \u2010treated rats, administration of\n                      <jats:styled-content style=\"fixed-case\">JNJ<\/jats:styled-content>\n                      \u201042905343 for 28 days corrected\n                      <jats:styled-content style=\"fixed-case\">FID<\/jats:styled-content>\n                      and anaemia, as reflected by increased blood haemoglobin,\n                      <jats:styled-content style=\"fixed-case\">MCH<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">MCV<\/jats:styled-content>\n                      . Increased expression of\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>DcytB<\/jats:italic>\n                      <\/jats:styled-content>\n                      and\n                      <jats:italic>DMT1<\/jats:italic>\n                      genes in the duodenum resulting in increased iron availability was defined as the mechanism for these effects. rhEPO did not affect\n                      <jats:styled-content style=\"fixed-case\">DcytB<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">DMT1<\/jats:styled-content>\n                      and was not effective in\n                      <jats:styled-content style=\"fixed-case\">PGPS<\/jats:styled-content>\n                      \u2010treated rats.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Implications<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">PHD<\/jats:styled-content>\n                      inhibition has a beneficial effect on iron metabolism in addition to stimulating the release of\n                      <jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>\n                      . Small\u2010molecule inhibitors of\n                      <jats:styled-content style=\"fixed-case\">PHD<\/jats:styled-content>\n                      such as\n                      <jats:styled-content style=\"fixed-case\">JNJ<\/jats:styled-content>\n                      \u201042905343 represent a mechanism distinct from\n                      <jats:styled-content style=\"fixed-case\">rhEPO<\/jats:styled-content>\n                      to treat anaemia and\n                      <jats:styled-content style=\"fixed-case\">FID<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bph.13188","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T23:51:20Z","timestamp":1431993080000},"page":"4078-4088","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation\u2010induced anaemia in rats"],"prefix":"10.1111","volume":"172","author":[{"given":"Terrance D","family":"Barrett","sequence":"first","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L","family":"Palomino","sequence":"additional","affiliation":[{"name":"School of Medicine University of California at San Diego  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa I","family":"Brondstetter","sequence":"additional","affiliation":[{"name":"Covenant Care  Palo Alto CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon C","family":"Kanelakis","sequence":"additional","affiliation":[{"name":"Office of Foods and Veterinary Medicine U.S. Food and Drug Administration  Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wu","sequence":"additional","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yan","sequence":"additional","affiliation":[{"name":"Arcturus Therapeutics  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P","family":"Merton","sequence":"additional","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Schoetens","sequence":"additional","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Ying","family":"Ma","sequence":"additional","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Skaptason","sequence":"additional","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjin","family":"Gao","sequence":"additional","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da\u2010Thao","family":"Tran","sequence":"additional","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"Venkatesan","sequence":"additional","affiliation":[{"name":"Cardiovascular Metabolic Research Janssen Pharmaceutical Companies of Johnson &amp; Johnson  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Rosen","sequence":"additional","affiliation":[{"name":"Aetheria Therapeutics  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel P","family":"Shankley","sequence":"additional","affiliation":[{"name":"Higher Todsworthy Farm  Cornwall UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Rabinowitz","sequence":"additional","affiliation":[{"name":"Aetheria Therapeutics  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12450"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12451"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.070508"},{"key":"e_1_2_10_5_1","first-page":"95A","article-title":"FG\u20104592, a novel oral HIF prolyl hydroxylase inhibitor (HIF\u2010PHI), elevates haemoglobin in anemic stage 3\u20134 CKD patients","volume":"21","author":"Besarab A","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1066373"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(01)00723-8"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2008.12.004"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00507-4"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111838"},{"key":"e_1_2_10_11_1","unstructured":"Guideline on the Humane Care & Use of Animals(2013). Available at:http:\/\/www.jnj.com\/sites\/default\/files\/pdf\/guideline\u2010on\u2010humane\u2010care\u2010and\u2010use\u2010of\u2010animals\u201020130322.pdf(accessed 10\/6\/2015)."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059817"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059796"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2007.00810.x"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087057109333976"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.991402"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38499"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.09.68"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1192811"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90104-9"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1143"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/ml100198y"},{"key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/iai.57.4.1177-1185.1989","article-title":"Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan\u2010polysaccharide polymers in rats","volume":"57","author":"Sartor RB","year":"1989","journal-title":"Infect Immun"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011165"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2008.12.012"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12311"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2008.08.006"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.13188","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.13188","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.13188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T02:16:12Z","timestamp":1696385772000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.13188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1111\/bph.13188"],"URL":"https:\/\/doi.org\/10.1111\/bph.13188","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]},"assertion":[{"value":"2015-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-05-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}